Highlights
NASDAQ: RPRX       Royalty Pharma Plc Cl A
Last Price Today's Change   Day's Range   Trading Volume
36.12   -1.75 (4.62%)  35.51 - 39.16  1,798,800

Overview

 
Avg Volume (4 weeks):1,769,080
4 Weeks Range:35.51 - 44.97
4 Weeks Price Volatility (%):
6.45%
52 Weeks Range:35.51 - 56.50
52 Weeks Price Volatility (%):
2.91%
Average Price Target: 35.00
Price Target Upside/Downside: -1.12

Headlines



No recent Headlines for this stock.


Business Background

Repros Therapeutics, Inc. is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. The Company's product candidates include enclomiphene, which is a single isomer of clomiphene citrate, an orally active small molecule compound, and Proellex, which is an orally administered selective blocker of the progesterone receptor in women, for the treatment of uterine fibroids and endometriosis. Enclomiphene is for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function. The Company's Proellex product candidate for female reproductive health is a chemical entity, which acts as a selective blocker of the progesterone receptor. It is being developed for the treatment of symptoms associated with uterine fibroids and endometriosis The Company has an active Investigational New Drug (IND) for the vaginal delivery of Proellex for the treatment of uterine fibroids.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1994  6612  492  172 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.039 
 GE 7.42+0.32 
 AAPL 111.20-5.40 
 SPY 326.66-11.56 
 SQQQ 24.65+2.59 
 UVXY 23.14+4.07 
 NIO 27.51-0.93 
 XLF 23.61-0.62 
 F 7.70-0.22